Dysfunction of the IL‐36 receptor antagonist (IL‐36Ra), encoded by IL36RN, initiates a downstream inflammatory cascade, while activation of CARD14, encoded by CARD14, promotes skin inflammation by activating NF‐κB in epidermal keratinocytes.1 This evidence concerns the gene CARD14 and dermatitis.